Apple’s chip maker Arm’s share price has dropped, despite upping its dividend by 25 per cent July 22, 2015 Apple's chip maker Arm Holdings's share price dipped this morning, despite upping its interim dividend 25 per cent after being buoyed by yet another strong quarter. The figures: Group revenues for the second quarter were up 15 per cent year-on-year in dollar terms, or 22 per cent in sterling. Most of that came from [...]
Barclays and UK fraud office eye deal over criminal probe into Qatar July 21, 2015 Barclays is widely believed to be in talks with the Serious Fraud Office (SFO) over a potential deal to resolve a long-running criminal probe into the bank’s dealings with Qatari investors in 2008. The SFO has proposed the possibility of a deferred prosecution agreement (DPA) linked to the bank’s fundraising activities during the financial crisis. [...]
Ashley Madison’s hacking affair: Is a London IPO now a fling too far after data breach? July 21, 2015 Ryainair boss Michael O’Leary is no shrinking violet, but even Ashley Madison, the controversial adultery website hacked on Monday, proved too much for the colourful Irishman. The Ryanair chief was offered €120,000 (£84,350) by Ashley Madison last year to paint its logo on one of its planes, but turned them down. The incident [...]
Rothesay Life racks up biggest buy-in of 2015 with new £1.6bn CAAPS deal July 21, 2015 Insurance firm Rothesay Life has completed a £1.6bn bulk annuity deal with the Civil Aviation Authority Pensions Scheme (CAAPS), the second largest buy-in ever secured by a UK pension scheme. The arrangement is also the largest de-risking transaction completed so far this year. Rothesay Life has now written £3.4bn of new business year-to-date in 2015. [...]
Apple Watch sales “beat internal forecasts”, selling more than iPad or iPhone in its first quarter July 21, 2015 As Apple released the first set of results from the tech giant to include Apple Watch sales, the one question everyone wanted answered was: How has the Apple Watch fared? A flop or a success for the company? Curious investors were left to wonder, however, as Apple did not break out unit sales for its [...]
Apple earnings: Profits soar as China continues to boost iPhone 6 sales – but share price slides seven per cent July 21, 2015 Despite beating analysts' sales and revenue expectations again, Apple share fell by seven per cent after the company reported selling fewer iPhones than forecast and lowered fourth quarter profit guidance. The figures Smashing through what is traditionally its slowest sales period, Apple has reported a quarterly record-high revenue of $49.6bn, beating analysts' forecasts for the [...]
Yahoo beats analysts’ expectations with fastest revenue growth since 2010 July 21, 2015 The figures At $1.24bn, Yahoo's sales smashed analysts' expectations. The company was expected to report a sinking revenue, with analysts forecasting revenues of $1.03bn, but instead reported a 15 per cent growth against the same period last year. Earnings are squeezed, however, with the company reporting earnings per share of $0.16, against expectations of $0.18. [...]
Tesla Motor’s share price down as analysts expect growth will “disappoint” July 21, 2015 Tesla shares were down after a UBS analyst downgraded it to “sell”, expecting disappointing growth from the company’s electric car and home battery segments. Shares slid 4.7 per cent for Tesla, the electric car manufacturer that has attracted a cult following, and were down to $269.10. UBS analyst Colin Langan wrote in a statement to [...]
Apple says Itunes and App Store suffering “glitches” – unavailable for some users July 21, 2015 Apple users are reporting technical glitches, with a whole host of their media functions struggling today, including the App Store and Itunes. The services are currently completely unavailable for some of its users. Apple has posted a statement: We are investigating and will update the status as more information becomes available. At least twelve Apple [...]
Novartis earnings plummet but major drug release paves the way for improvement July 21, 2015 Earnings fell by 32 per cent at Novartis in the second quarter, but new medicine releases are expected to counteract the negative impact. Read more: Novartis accused of losing money for the NHS by blocking competitor drug trial During the three months ending June, net income was $1.86bn (£1.2bn) for the Swiss pharmaceutical giant, [...]